Diane S. Aschenbrenner
* The methylphenidate transdermal system (Daytrana), a patch used to treat attention deficit–hyperactivity disorder, can produce a permanent loss of skin color. Such losses usually develop close to where the patches are worn, although they may develop elsewhere on the body.